These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 24335745)
1. Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes. Anschuetz G; Asbel L; Salmon ME; Johnson CC Sex Transm Dis; 2014 Jan; 41(1):64-6. PubMed ID: 24335745 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011-2012. Tabidze IL; Nicholson TF; Mikati T; Benbow N; Mehta SD Sex Transm Dis; 2015 Aug; 42(8):422-8. PubMed ID: 26165433 [TBL] [Abstract][Full Text] [Related]
3. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011. Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391 [TBL] [Abstract][Full Text] [Related]
5. National sentinel surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Commun Dis Rep CDR Wkly; 2000 Jun; 10(22):195, 198. PubMed ID: 10881399 [No Abstract] [Full Text] [Related]
6. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae. Golden MR; Barbee LA; Kerani R; Dombrowski JC Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259 [TBL] [Abstract][Full Text] [Related]
7. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837 [TBL] [Abstract][Full Text] [Related]
8. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Cole MJ; Chisholm SA; Hoffmann S; Stary A; Lowndes CM; Ison CA; Sex Transm Infect; 2010 Nov; 86(6):427-32. PubMed ID: 20940154 [TBL] [Abstract][Full Text] [Related]
9. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines. Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973 [TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233 [TBL] [Abstract][Full Text] [Related]
11. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269 [TBL] [Abstract][Full Text] [Related]
13. [Current status of the antibiotic resistance of Neisseria gonorrhoeae]. Lind I Z Hautkr; 1985 Sep; 60(18):1461-71. PubMed ID: 3933201 [TBL] [Abstract][Full Text] [Related]
14. [The role of the variability of gonococci in the development of therapeutic-prophylactic measures in gonorrhea]. Mavrov II; Gorisiuk AF Mikrobiol Zh (1978); 1987; 49(4):62-4. PubMed ID: 3150499 [No Abstract] [Full Text] [Related]
15. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda. Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585 [TBL] [Abstract][Full Text] [Related]
17. Underreporting and underestimation of gonorrhea cases in the Taiwan National Gonorrhea Notifiable Disease System in the Tainan region: evaluation by a pilot physician-based sentinel surveillance on Neisseria gonorrhoeae infection. Hsieh YH; Kuo MJ; Hsieh TC; Lee HC Int J Infect Dis; 2009 Nov; 13(6):e413-9. PubMed ID: 19394259 [TBL] [Abstract][Full Text] [Related]
18. Treatment of gonorrhea: what effect will antibiotic resistance have in the future? Sparling PF Sex Transm Dis; 1979; 6(2 Suppl):120-5. PubMed ID: 115098 [No Abstract] [Full Text] [Related]
19. [Acute gonorrhea. Treatment schedules. Evaluation]. Belli L; Casco RH; Melgar A; Mugico B; Famiglietti AM; Griemberg G Med Cutan Ibero Lat Am; 1989; 17(5):299-302. PubMed ID: 2516187 [TBL] [Abstract][Full Text] [Related]
20. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]